{"id":"W4416019191","doi":"10.1016/j.ijgc.2025.102617","title":"REJOICE-OVARIAN02: A PHASE 1B/2 STUDY OF RALUDOTATUG DERUXTECAN WITH OTHER ANTICANCER AGENTS IN PARTICIPANTS WITH RELAPSED OVARIAN CANCER AFTER PLATINUM-BASED CHEMOTHERAPY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Carboplatin; Ovarian cancer; Bevacizumab; Paclitaxel; Chemotherapy; Phases of clinical research; Topoisomerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002221461,0.001343001,0.002753027,0.0005109631,0.0006396598,0.001153177,0.0009476185,0.00170147,0.004922076],"category_scores_gemma":[0.001255075,0.0008342731,0.002258369,0.0004867082,0.001318555,0.001017523,0.0006311722,0.003954956,0.0008879547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001064226,"about_ca_system_score_gemma":0.002073671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002625433,"about_ca_topic_score_gemma":0.008659339,"domain_scores_codex":[0.9992682,0.0003358138,0.00003434611,0.0001408631,0.00006331257,0.0001575792],"domain_scores_gemma":[0.9990515,0.0001325359,0.0001597762,0.00009250717,0.00006544439,0.0004980881],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8369059,0.07828268,0.01336075,0.0007786404,0.002545126,0.00009211531,0.0003072451,0.0005856577,0.01658047,0.000173272,0.001831827,0.04855635],"study_design_scores_gemma":[0.5932136,0.3756377,0.02477183,0.0000438013,0.001438576,0.0001087352,0.0001312892,0.0003691302,0.001598444,0.0001441665,0.00250709,0.00003560895],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944319,0.00144531,0.0002373278,0.0003520099,0.0001020833,0.001802635,0.0008341137,0.00005457107,0.0007401292],"genre_scores_gemma":[0.9874792,0.001790101,0.00159868,0.001046481,0.0001975426,0.003112515,0.001775285,0.00004293356,0.002957325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004922076,"threshold_uncertainty_score":0.01646596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02738652279505877,"score_gpt":0.3559953659501616,"score_spread":0.3286088431551029,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}